How Will Psychedelics Change The Landscape?

The research data on psychedelics keeps coming. A study on psilocybin for major depressive disorder (MDD) found a reduction in symptoms for up to four weeks (see Magic Mushroom Therapy Found Effective For Treating Depression). Methylenedioxymethamphetamine (MDMA) has shown effectiveness in treating post-traumatic stress disorder (PTSD) (see Phase 3 Trial Evaluating MDMA-Assisted Therapy For PTSD Meets Endpoints). And a ketamine analogue psychedelic, 2-Fluorodeschloroketamine (2-FDCK), is also showing high potential for the treatment of acute and chronic depression (see Israeli Biotech Clearmind Medicine Announces Positive Pre-Clinical Results Treating Major Depression With A Novel Ketamine-Based Compound . . .